Abstract: Fifteen N 4 -benzyl-substituted isatin-3-thiosemicarbazones 5a-o were synthesized and evaluated for their urease and glycation inhibitory potential. Lemna aequinocitalis growth and Artemia salina assays were also done to determine their phytotoxic and toxic effects. All compounds are potent inhibitors of the urease enzyme, displaying inhibition [half maximal inhibitory concentration (IC 50 ) = 1.08 ± 0.12-11.23 ± 0.19 μm] superior to that of the reference inhibitor thiourea (IC 50 = 22.3 ± 1.12 μm). Compounds 5c, 5d, 5h, 5j,k are potent antiglycating agents, showing glycation inhibitory activity better than that of the reference inhibitor rutin (IC 50 values 209.87 ± 0.37-231.70 ± 6.71 vs. 294.5 ± 1.5 μm). In the phytotoxicity assay, 11 thiosemicarbazones 5a-d, 5g, 5h, 5j-l, 5n,o are active, demonstrating 5-100% growth inhibition of L. aequinocitalis at the highest tested concentrations (1000 or 500 μg/mL). In the brine shrimp (A. salina) lethality bioassay, three derivatives 5b, 5j and 5o are active with median lethal dose (LD 50 
Introduction
Isatin and its derivatives, including thiosemicarbazones exhibit a variety of biological properties such as antiulcer [1] , anticancer [1, 4, 7, 12, 21, 22] , antimicrobial [1-3, 5, 7, 22] , antitubercular [23] [24] [25] , antiviral [1, 2, 5, 7, 12, 25] and enzymatic inhibition [1, 4, 11, 17] activities. We have recently reported the synthesis of a number of N 4 -aryl-substituted isatin-3-thiosemicarbazones (thiourea derivatives) as antimicrobial [26, 27] , cytotoxic [27] [28] [29] , phytotoxic [28, 29] and antiurease [27, 28] agents. The structure-activity relationship studies have revealed that in some cases, the kind, number and position of substituents on the phenyl ring attached to the N 4 atom of the thiosemicarbazone moiety play a key role in the biological properties, including urease inhibition. Several thiourea derivatives demonstrate promising antiglycation activity [30] [31] [32] [33] [34] and certain isatin-imines (Schiff bases) are potent inhibitors of glycation [35, 36] . Stimulated by the above observations and in continuation of our efforts [37] [38] [39] [40] [41] [42] [43] [44] in search of novel isatin-based bioactive organic molecules with diverse pharmacological properties, we have synthesized 15 new title thiosemicarbazones and evaluated them for the first time for urease and glycation inhibitory effects. Lemna aequinocitalis growth and Artemia salina assays were also done to determine their phytotoxic and toxic influences, respectively.
Results and discussion

Chemistry of compounds 5a-o
Appropriate N-substituted thiosemicarbazides 3 were allowed to react with isatin 4 in aqueous ethanol to give the corresponding isatin-3-thiosemicarbazones 5a-o (Scheme 1) in good to excellent yields (73-95%). Compounds 5a and 5k have been reported previously [45, 46] . The structures of the synthesized thiosemicarbazones were confirmed by analytical and spectral data. In addition, X-ray crystallographic analysis for compound 5h was conducted. The spectral data are in line with the relevant literature [22, 24, 47, 48] .
X-ray crystallographic analysis of compound 5h
Quality crystals of 5h (Table S1) were cultivated by slow evaporation of the solution in CHCl 3 . The X-ray analysis shows that compound 5h crystallizes in monoclinic lattice with the P2 1 /c space group. The molecular structure [Oak Ridge Thermal-Ellipsoid Plot (ORTEP) diagram] of 5h along with crystallographic numbering scheme is presented in Figure 1 In crystal, compound 5h forms a centrosymmetric amide dimer as the major supramolecular interaction, dominating over a thioamide dimer. The three-dimensional (3D) network structure of 5h is composed of various onedimensional (1D) tapes (Figure 2A 
In vitro antiurease activity
The N 4 -benzyl-substituted isatin-3-thiosemicarbazones 5a-o were evaluated for their antiurease activity against jack bean urease. Thiourea served as a reference inhibitor in this assay. All compounds are potent inhibitors of the enzyme, exhibiting inhibitory activity [half maximal inhibitory concentration (IC 50 ) = 1.08 ± 0.12-11.23 ± 0.19 μm], which is better than the activity of the reference inhibitor thiourea (IC 50 = 22.3 ± 1.12 μm) ( Table 1) . In comparison to compound 5a having no substituent in the phenyl ring of the benzyl group attached to N 4 of the thiosemicarbazone moiety, all other compounds demonstrate enhanced enzymatic activity (IC 50 values 1.08 ± 0.12-7.97 ± 0.14 vs. 11.23 ± 0.19 μm). Compound 5f bearing a methoxy substituent at position 3 of the phenyl ring is the most potent urease inhibitor of the series, displaying 10-and 20-fold more activity than compound 5a and the reference inhibitor thiourea (IC 50 = 1.08 ± 0.12 vs. 11.23 ± 0.19 and 22.3 ± 1.12 μm, respectively). The other methoxy-substituted compounds 5e and 5g having the substituent at positions 2 and 4 of the phenyl ring are less active with IC 50 values of 1.51 ± 0.26 and 3.11 ± 0.13 μm, respectively. The next most potent antiurease compound is 5b possessing the methyl substituent at position 2 of the phenyl ring. This compound exhibits slightly lower inhibitory activity than 5f but is more active than the reference inhibitor thiourea (IC 50 value 1.22 ± 0.17 vs. 1.08 ± 0.12 and 22.3 ± 1.12 μm, respectively). Comparison of the antiurease activity of compound 5b with that of closely related methyl-substituted compounds 5c and 5d having the substituent at positions 3 and 4 of the phenyl ring, respectively, reveals that methyl substitution at position 2 of the phenyl is more favorable than at positions 3 and 4. Compound 5c is less active than 5b but considerably more active than 5d (IC 50 value 1.62 ± 0.13 vs. 1.22 ± 0.17 and 2.17 ± 0.11 μm, respectively). The N 4 -benzyl-substituted isatin-thiosemicarbazones tested in the present assay, 5a-i and 5k-m, are more active in comparison to the corresponding N 4 -phenyl-substituted isatinthiosemicarbazones tested in our earlier assays [27, 28] .
In vitro antiglycation activity
The thiosemicarbazones 5a-o were further evaluated for their glycation inhibitory potential using rutin as a reference inhibitor. Seven compounds 5b-d, 5f, 5h, 5j,k, proved to be potent inhibitors of glycation. Compounds 5c, 5d, 5h, 5j,k show antiglycation activity even better than the reference inhibitor rutin (Table 2) Reference inhibitor of urease enzyme.
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The isomer 5c having the substituent at position 3 of the phenyl ring has the IC 50 value of 231.70 ± 6.7 μm. This compound is significantly more active than the corresponding methoxy-substituted derivative 5f. The next most potent antiglycating agent is compound 5j possessing a fluoro substituent at position 4 of the phenyl ring. This compound exhibits slightly less inhibition than the most active derivative 5d but a great deal more than the reference inhibitor rutin. Overall, compounds with the CH 3 , F and Cl substitutions cause effective inhibition of glycation.
In vitro phytotoxicity
Phytotoxic potential of compounds 5a-o was determined by L. aequinocitalis growth bioassay. Eleven compounds, 5a-d, 5g, 5h, 5j-l, 5n,o, are active in this assay, displaying weak or non-significant (5-100%) growth inhibition of L. aequinocitalis at the highest tested concentrations (1000 or 500 μg/mL) in comparison to the standard drug, paraquat, which shows 100% plant growth inhibition at 0.015 μg/mL concentration.
In vitro toxicity
Toxicity potential of compounds 5a-o was determined by a brine shrimp (A. salina) lethality bioassay, using etoposide (a standard anticancer drug) as a reference. Compounds 3b, 3j and 3o are active in this assay, demonstrating moderate to weak toxicity [median lethal dose (LD 50 
Molecular docking studies of compounds 5a-o
Molecular docking studies were performed as previously reported [52] [53] [54] [55] [56] [57] [58] . Docking studies of compound 5f against urease was carried out to gain further structural insights of the binding mode and possible interactions with the active site of the enzyme. Binding mode analysis of compound 5f with urease, selected after Hyde assessment, is given in Figure 3 . Docking studies support the experimental results that inhibitors bind with the catalytic site of the enzyme. The interactions within the active pocket of the receptor for its ligand are very important in the design of inhibitors. The π-stacked interactions are suggested for 3-methoxyphenyl ring of the inhibitor in the active site with residues His519, His593 and Arg609. 2-Oxoindolin-3-ylidene moiety is oriented in the hydrophobic pocket of the active site, where amino acid residues Ala636 and Met637 are present. Moreover, polar interactions are observed by the central thiosemicarbazone moiety and the amino acid residues Arg439, Ala436 and Ala440. 
Conclusions
All compounds 5a-o are extremely potent inhibitors of the urease enzyme. In addition, compounds 5c, 5d, 5h, 5j,k inhibit glycation quite convincingly. The glycation inhibitory activity of N 4 -benzyl-substituted isatin-3-thiosemicarbazones is described here for the first time.
Experimental
Melting points (uncorrected) were determined on a Fisher-Johns melting point apparatus. Elemental analyses were performed on a Leco CHNS-9320 (USA) elemental analyzer. Fourier transforminfrared (FT-IR) spectra (KBr discs) were recorded on a Shimadzu Prestige-21 FT-IR spectrophotometer. Proton nuclear magnetic resonance ( 1 H NMR) spectra were measured in dimethyl sulfoxide-d6 (DMSO-d 6 ) on Bruker Spectrospin 300 and Bruker AVANCE 400 spectrometers operating at 300 MHz and 400 MHz, respectively. Carbon-13 nuclear magnetic resonance ( 13 C NMR) spectra were recorded in DMSO-d 6 on Bruker AVANCE 300 operating at 75 MHz. Electron impact mass spectra were obtained at 70 eV on MAT312 and JEOL JMS-600 mass spectrometers. X-ray crystallographic data were taken on a Bruker Kappa APEXII charge coupled device (CCD) instrument. Compounds 5a and 5k have been reported previously [45, 46] .
Synthesis of isatin-thiosemicarbazones 5a-o
N-substituted thiosemicarbazides 3a-o were synthesized in accordance with the literature route [59] .
A solution of thiosemicarbazide 3 (5 mmol) in ethanol (10 mL) was added to a hot solution of isatin 4 (5 mmol) in 50% aqueous ethanol (15 mL), and the mixture was heated under reflux for 2 h. The resultant crystalline precipitate was filtered and washed with hot aqueous ethanol to afford the desired compounds 5a-o. N -( 4-M e t hyl b e n z yl ) -2-( 2-oxo -2 , 3 -d i hyd r o -1 H -i n d o l -3-ylidene)-1-hydrazinecarbothioamide (5d (13), 178 (38), 161(20), 147 (100), 132 (13), 120 (67), 118 (62) N -( 2-F l u o r o b e n z y l ) -2-[ 2-oxo -2 , 3 -d i hyd r o -1 H -i n d o l -3-ylidene]-1-hydrazinecarbothioamide (5h CH 2 ), 111.1, 114.9, 115.2, 119.9, 120.9, 122.3, 124.2, 124.3,  124.9, 125.1, 128.9, 128.9, 131.3, 132.2, 142.4, 161.4 N-(2, 4-Dichlorobenzyl)-2-[2-oxo-2,3-dihydro-1H-indol-3 
N -( 2-M e t hyl b e n z yl ) -2-[ 2-oxo -2 , 3 -d i hyd r o -1 H -i n d o l -3-ylidene]-1-hydrazinecarbothioamide (5b) Yellow
N-(3-Methylbenzyl)-2-[2-oxo-2,3-dihydro-1H-indol-3-ylidene]-1-
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Crystallographic data collection and structural refinement
A crystal of 5h was mounted on a thin glass fiber at room temperature and the reflection data were collected on a Bruker Kappa APE XII CCD diffractometer equipped with graphite monochromated MoKα radiation (λ = 0.71073 Å). The data were corrected for Lorentz and polarization effects. The structure was solved using SHELXS-97 [51] . A final refinement on F 2 was carried out by full-matrix least-squares techniques using SHELXL-97 [51] .
Biological assays
In vitro antiurease, antiglycation, phytotoxic and toxic activities of thiosemicarbazones 5a-o were performed by using the reported methods [52, 36, 38, 41] .
Molecular docking studies
Docking studies of compounds 5a-o were carried out in accordance with the previously described protocols [52] [53] [54] [55] [56] [57] [58] .
